Recent studies in stroma-heavy tumors such as microsatellite-stable (MSS) CRC and urothelial cancer demonstrate the ability of TGFβ inhibition to turn these immunologically cold tumors, with poor CD8+ T cell infiltration, into hot tumors with an increased infiltration of cytotoxic CD8+ T cells. The gene discussed is CD8A; the disease is colorectal carcinoma.